Western European markets for biosimilar drugs: worth differentiation

Research output: Contribution to conferencePaper

Abstract

This paper discusses pharmaceutical expenditure in OECD countries.

Conference

ConferenceThe Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe
CountrySerbia
CityBelgrade
Period9/10/1510/10/15

Fingerprint

Biosimilar Pharmaceuticals
Health Expenditures
Pharmaceutical Preparations
Organisation for Economic Co-Operation and Development
Expenditure
Drugs
Pharmaceuticals
OECD countries

Keywords

  • pharmaceutical expenditure
  • medication costs
  • pharmacoeconomics

Cite this

Godman, B. (2015). Western European markets for biosimilar drugs: worth differentiation. Paper presented at The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe, Belgrade, Serbia.
Godman, Brian. / Western European markets for biosimilar drugs : worth differentiation. Paper presented at The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe, Belgrade, Serbia.
@conference{001eee2f4fcd40129a5e0b9fc03698e0,
title = "Western European markets for biosimilar drugs: worth differentiation",
abstract = "This paper discusses pharmaceutical expenditure in OECD countries.",
keywords = "pharmaceutical expenditure, medication costs, pharmacoeconomics",
author = "Brian Godman",
year = "2015",
language = "English",
note = "The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe ; Conference date: 09-10-2015 Through 10-10-2015",

}

Godman, B 2015, 'Western European markets for biosimilar drugs: worth differentiation' Paper presented at The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe, Belgrade, Serbia, 9/10/15 - 10/10/15, .

Western European markets for biosimilar drugs : worth differentiation. / Godman, Brian.

2015. Paper presented at The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe, Belgrade, Serbia.

Research output: Contribution to conferencePaper

TY - CONF

T1 - Western European markets for biosimilar drugs

T2 - worth differentiation

AU - Godman, Brian

PY - 2015

Y1 - 2015

N2 - This paper discusses pharmaceutical expenditure in OECD countries.

AB - This paper discusses pharmaceutical expenditure in OECD countries.

KW - pharmaceutical expenditure

KW - medication costs

KW - pharmacoeconomics

UR - http://www.farmakoekonomija.org/files/presentations/vconf/3.1%20Presentation%20Biosimilars%20Brian%20Godman%20Belgrade%20Oct%202015.pdf

M3 - Paper

ER -

Godman B. Western European markets for biosimilar drugs: worth differentiation. 2015. Paper presented at The Fifth International Conference of the Pharmaceutical Association of Serbia Pharmacoeconomics Section: Challenges for Efficient Health Care in Central and Eastern Europe, Belgrade, Serbia.